Authors:
ESCHBACH J
DEOREO P
ADAMSON J
BERNS J
BIDDLE G
COMSTOCK T
JABS K
LAZARUS JM
NISSENSON A
STIVELMAN J
VANWYCK D
WISH J
Citation: J. Eschbach et al., NKF-DOQI CLINICAL-PRACTICE GUIDELINES FOR THE TREATMENT OF ANEMIA OF CHRONIC-RENAL-FAILURE, American journal of kidney diseases, 30(4), 1997, pp. 192-240
Citation: A. Sehgal et al., THE PREVALENCE, RECOGNITION, AND IMPLICATIONS OF MENTAL IMPAIRMENT AMONG DIALYSIS PATIENTS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 1246-1246
Citation: Km. Erbeck et al., EFFECT OF HEMODIALYSIS ACCESS ON DELIVERED DOSE OF DIALYSIS (KT V)/, Journal of the American Society of Nephrology, 6(3), 1995, pp. 487-487
Authors:
WARD RA
BRIER ME
DEOREO P
ERBECK KM
HAMBURGER RJ
SMITH BA
Citation: Ra. Ward et al., PREDICTORS OF SHORT-TERM MORTALITY IN DIABETIC HEMODIALYSIS-PATIENTS, Journal of the American Society of Nephrology, 6(3), 1995, pp. 567-567
Citation: P. Deoreo et Rj. Hamburger, UREA REDUCTION RATIO (URR) IS NOT A CONSISTENT PREDICTOR OF KT V/, Journal of the American Society of Nephrology, 6(3), 1995, pp. 597-597
Citation: Me. Brier et al., DIABETES AND DELIVERED DOSE OF HEMODIALYSIS IN 1994 - NETWORK-9 ADEQUACY STUDY, Journal of the American Society of Nephrology, 5(3), 1994, pp. 510-510